We are pleased to announce the following webinar activity is now available on www.powerpak.com |
|
Goal To inform and educate pharmacists on the most up-to-date information on the use of GLP-1 RAs in patients with T2D, including in-depth discussions of new agents, review and application of current clinical practice recommendations, review of data on cardiovascular outcomes, and practical discussions regarding patient management. This educational initiative will provide learners with the knowledge and competence to improve the care and outcomes of patients with T2D. |
Learning Objectives |
• |
Describe practical considerations for use of GLP-1 RAs in combination with other glucose-lowering agents |
• |
Discuss selection of GLP-1 RA based on clinical needs, administration and device implications |
• |
Explain practical strategies and considerations for GLP-1 RA product substitutions |
• |
Recognize key safety and tolerability considerations with use of specific GLP-1 RA products |
UAN: 0430-0000-20-124-L01-P Credits: 1.25 hour (0.125 ceu) Duration: 75 minutes Location: From the convenience of your home or business; accessible via both PC and MAC Fee: There is no fee for this educational activity Target Audience: Pharmacists Type of Activity: Application |
|
Agenda |
|
Introduction (5 minutes) Presentation (60 minutes) Conclusions & Question & Answer Session (10 minutes) |
|
How to Earn Credit Participants must 1) read the learning objectives and faculty disclosures; 2) attend and participate in the live webinar; and 3) complete the evaluation form directly after the event with a maximum of within 60 days of attending the live session. To answer the questions, click on your selected choice for each answer then proceed to the next question. Your credit will automatically uploaded to CPE Monitor. |
Required Computer Hardware/Software |
|||||||||||||||||
|
|